Polarean receives FDA approval for drug device combination product
28th Dec 2022 08:10
(Sharecast News) - Medical imaging technology group Polarean said on Wednesday that its drug device combination product has been granted approval by the US Food and Drug Administration.
Read morePolarean inks long Covid research deal with Oxford NHS trust
11th May 2022 12:58
(Sharecast News) - Medical imaging technology company Polarean announced a research collaboration with Oxford University Hospitals NHS Foundation Trust (OUH) on Wednesday, to study the long-term effects of Covid-19 in patients with breathing difficulties months after initial infection.
Read morePolarean Imaging receives research order from long-standing partner
25th Apr 2022 09:11
(Sharecast News) - Medical imaging technology company Polarean Imaging has received an additional research unit order for a xenon polariser '9820', it announced on Monday.
Read moreFDA accepts Polarean's medical imaging drug-device resubmission
20th Apr 2022 12:41
(Sharecast News) - Medical imaging technology company Polarean Imaging updated the market on its investigational drug‑device combination product on Wednesday, which uses hyperpolarised '129Xenon' gas to enhance magnetic resonance imaging (MRI) in pulmonary medicine.
Read morePolarean installs xenon polariser system at Vancouver hospital
11th Oct 2021 15:00
(Sharecast News) - Medical imaging technology company Polarean Imaging announced the installation of its 9820 xenon polariser system at BC Children's Hospital in Vancouver on Monday.
Read morePolarean Imaging gets another research unit order
10th May 2021 13:49
(Sharecast News) - Medical imaging technology company Polarean Imaging has received an additional research unit order for a '9820 Xenon Polariser' system from the University of British Columbia (UBC), it announced on Monday.
Read moreIntuitive Investments puts £0.25m into Polarean Imaging
17th Mar 2021 14:16
(Sharecast News) - Life science-focussed closed-end investment company Intuitive Investments said on Wednesday that it was acquiring 416,666 shares of Polarean Imaging at a price of 60p each, for a total of £0.25m.
Read morePolarean Imaging new drug application gets FDA acceptance
23rd Dec 2020 11:38
(Sharecast News) - Medical imaging technology company Polarean Imaging updated the market on the status of its new drug application with the US Food and Drug Administration (FDA) on Wednesday.
Read morePolarean Imaging installs research unit at University of Kansas
18th Sep 2020 11:16
(Sharecast News) - Medical imaging technology company Polarean Imaging has installed its latest research unit order for a '9820 Xenon Polariser' system at the University of Kansas Medical Center, it announced on Friday.
Read morePolarean Imaging delivers and installs latest research unit order
24th Dec 2019 07:54
(Sharecast News) - Medical imaging technology company Polarean Imaging has delivered and installed its latest research unit order for a '9820 Xenon Polariser' system from the University of Iowa Hospitals and Clinics, it announced on Tuesday.
Read morePolarean delivers and installs new unit to University of BC
12th Nov 2019 16:02
(Sharecast News) - Medical imaging technology company Polarean Imaging announced on Tuesday that it has delivered and installed its latest research unit order for a '9820 Xenon Polariser' system from the University of British Columbia.
Read morePolarean Imaging completes enrolment for phase 3 trial
7th Nov 2019 11:51
(Sharecast News) - Medical imaging technology company Polarean Imaging, which has a proprietary magnetic resonance imaging (MRI) drug-device combination, announced on Thursday that the enrolment for its phase 3 non-inferiority clinical trials was now complete for both the lung transplant pathway and the lung resection pathway.
Read morePolarean Imaging revenues climb as clinical trial nears completion
27th Jun 2019 10:02
(Sharecast News) - Polarean Imaging's shares climbed on Thursday after reporting that its annual revenues doubled to come in slightly above expectations as sales in the US soared.
Read morePolarean names Charles Osborne as new CFO
29th Apr 2019 09:24
(Sharecast News) - Clinical stage medical-imaging technology outfit Polarean tapped former Innocrin Pharmaceuticals finance boss Charles Osborne Jr to take over as its chief financial officer on Monday.
Read more